Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to 0.22%.

  • Resmed's Return on Invested Capital rose 100.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.23% for FY2025, which is 400.0% up from last year.
  • Latest data reveals that Resmed reported Return on Invested Capital of 0.22% as of Q4 2025, which was up 100.0% from 0.22% recorded in Q3 2025.
  • Resmed's Return on Invested Capital's 5-year high stood at 0.22% during Q4 2025, with a 5-year trough of 0.13% in Q1 2021.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.18% (2022), whereas its average is 0.18%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -600bps in 2021, then surged by 700bps in 2022.
  • Resmed's Return on Invested Capital (Quarter) stood at 0.14% in 2021, then rose by 24bps to 0.17% in 2022, then dropped by -6bps to 0.16% in 2023, then surged by 32bps to 0.22% in 2024, then grew by 4bps to 0.22% in 2025.
  • Its Return on Invested Capital stands at 0.22% for Q4 2025, versus 0.22% for Q3 2025 and 0.22% for Q2 2025.